COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches

New Paper by NIIMA Interest Group

🔹the present study aimed to delineate the relationship between hematological diseases and malignancies and the novel COVID-19, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

🔹Besides, effective treatment options for patients with hematological diseases and malignancies were further explored to address this epidemic and its variants.

▫️Source: https://doi.org/10.1186/s12964-023-01316-9

@niima_usern
@usern_net